GemVax&KAEL Co.,Ltd.

Informe acción KOSDAQ:A082270

Capitalización de mercado: ₩398.1b

GemVax&KAELLtd Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Sang-Jae Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO2.6%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

Jul 05
Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem

Apr 03
GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem

Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?

Feb 17
Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?

Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%

Dec 26
Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%

CEO

Sang-Jae Kim (58 yo)

no data

Permanencia

Mr. Sang-Jae Kim serves as Chief Executive Officer at GemVax&KAEL Co.,Ltd. He serves as Co-Chief Executive Officer of BIOVILL Co.,Ltd. (formerly known as KSCB Co.,Ltd.) Mr. Kim serves as the Chief Executiv...